The RBB Fund, Inc.- US Treasury 5 Year Note ETF Price & Performance (UFIV)

Needham & Company LLC has lowered its price target for Dun & Bradstreet from $17 to $14, citing weaker-than-expected earnings. The company reported a quarterly EPS of $0.27, falling short of the $0.32 consensus. Despite the setback, analysts maintain a mix of "buy" and "hold" ratings on the stock.1

HCA Healthcare continues to receive a "Moderate Buy" consensus from analysts, even as some reduced their price targets. The stock's average target is now $385.67. Recent earnings showed $6.22 EPS, surpassing estimates. However, its debt-to-equity ratio of 69.07 raises concerns amid a volatile healthcare sector.2

Cintas Corporation has been assigned a "Hold" consensus rating by analysts, with price targets ranging from $185 to $240. The company recently reported $1.09 EPS, exceeding expectations. Cintas also announced a quarterly dividend of $0.39 per share, representing a 0.76% annual yield, which may attract income-focused investors.3